EU Fails to Address Smoking with Global Health Strategy

Dec.06.2022
EU Fails to Address Smoking with Global Health Strategy
The EU's global health strategy ignored e-cigarettes, drawing criticism from experts and consumer groups. A new tax plan raises concerns.

On December 5th, the European Commission (EC) announced its "Global Health Strategy" which aims to prioritize tackling the root causes of poor health. However, the strategy failed to address the issue of smoking through means of reducing tobacco harm.


The director of the World Vapers' Alliance (WVA), Michael Landl, has emphasized that the European Union (EU) has disregarded the science behind electronic cigarettes.


He stated: "The European Commission has once again ignored the voices of science and consumers. Reducing tobacco harm must be a key element of all EU health policies. 700,000 people die each year from smoking, while the Commission fights against less harmful alternatives. Science is clear that the harm of electronic cigarettes is much lower than smoking and they are one of the most effective smoking cessation aids. Consumers are demanding that the Commission finally accept this reality.


Meanwhile, in light of potential backlash against European Union efforts to reduce smoking rates, the EU has leaked a draft plan to increase taxes on electronic cigarette products, causing concern among the public. Experts in tobacco harm reduction and consumer groups have emphasized that such a tax would not only have adverse effects on public health, but could also create a large-scale new black market for electronic cigarette products.


The committee claims that increasing taxes will improve public health, but the facts say the opposite. Ordinary smokers trying to quit must be able to afford a less harmful substitute such as e-cigarettes. If the committee wants to mitigate the burden of smoking on public health, they must make e-cigarettes more affordable and accessible, not less," said Michael Landl, director of the World Vapers' Alliance (WVA).


2FIRSTS will continue to cover this topic, with updates available on the '2FIRSTSAPP.' Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan will implement price increases centered on heated tobacco products from April 1, 2026, following a tobacco tax hike. BAT Japan has decided to keep current prices unchanged for 38 glo-compatible tobacco stick products across the Velo, neo, Lucky Strike, and Kent lines.
Mar.30 by 2FIRSTS.ai
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Newly published patent filings indicate that China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), is exploring nicotine pouch technologies capable of releasing gas during oral use. The designs include carbon-dioxide microcapsules that burst in the mouth and effervescent systems that generate gas through chemical reactions with saliva, suggesting efforts to introduce new sensory dynamics into modern oral nicotine products.
News
Mar.04
South Dakota Legislature Approves Two Nicotine Licensing Bills Pending Governor’s Decision
South Dakota Legislature Approves Two Nicotine Licensing Bills Pending Governor’s Decision
The South Dakota Legislature gave final approval on Tuesday to two proposals requiring state licenses for businesses that sell nicotine products. Under the bills, wholesalers, distributors and retailers of nicotine products in the state would need to be licensed by the government.
Mar.12 by 2FIRSTS.ai
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
VOOPOO’s website shows the company has introduced the NAVI×Cyph Kit 80K, an open-system, refillable vaping kit claimed to deliver up to 80,000 puffs. The device features a 1,500mAh battery with USB Type-C charging and comes in 12 flavors. A promotional image posted on VOOPOO’s official Instagram account includes the phrase “E-LIQUID BUILT IN THE USA.”
Feb.10 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11